[1] Rott R. The pathogenic determinant of influenza virus[J]. Veterinary Microbiology, 1992, 33: 303-310.
[2] Trampuz A, Prabhu R M, Smith T F, et al. Avian influenza: a new pandemic threat?[J]. Mayo Clin Proc, 2004, 79 (4): 523-530.
[3] 于康震, 崔尚金, 付朝阳, 等. 禽流感与养禽业发展和人类健康[J]. 中国预防兽医学报, 2000, 22(4): 312-313.
[4] 刘红旗, 刘秀梵, 张如宽. A型流感病毒蛋白研究进展[J]. 动物医学进展, 2002, 23(2), 6-9.
[5] Brugh M, Stone H D. Immunization of chickens against influenza with hemagglutinin specific (H5) oil emulsion vaccine[C]//Proceedings of the Second International Symposium on Avian Influenza. U S Animal Health Association: Richmond, VA. 1987: 283-292.
[6] Mitnaul L J, Matrosovich M, Castrucci M R. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus[J]. J Virol, 2000, 74: 6015-6020.
[7] 韩凌霞. 鸡马立克氏病病毒毒力变异及疫苗的发展状况[J]. 中国家禽, 2000, 22(12): 35-37.
[8] Sonoda K, Sakaguchi M, Okamura H. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies[J]. J Virol, 2000, 74(7): 3217-3226.
[9] Tsukamoto K, Kojima C, Komori Y, et al. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2[J]. Virology, 1999, 257 (2): 352-362.
[10] 周雪媚, 李永清, 佘锐萍, 等. 表达传染性法氏囊(IBDV)VP2基因的重组马立克氏病病毒的构建[J]. 病毒学报, 2005, 21(6): 474-477.
[11] 黄冬艳, 杨兵, 齐欣, 等. 鸡贫血病毒VP1基因的克隆及其在大肠杆菌中的表达[J]. 华北农学报, 2006, 21(5): 50-53.
[12] 杨兵, 徐福洲, 王金洛, 等. 应用PCR方法检测鸡传染性贫血病毒[J]. 华北农学报, 2003, 18(3): 90-92. |